Xencor, Inc.
Clinical trials sponsored by Xencor, Inc., explained in plain language.
-
Lung cancer drug combo study halted early
Disease control TerminatedThis study tested a new drug called vudalimab combined with chemotherapy for people with advanced non-small cell lung cancer. The goal was to find the right dose and see if it works better than the standard treatment. The study was stopped early, and only 28 people took part.
Phase: PHASE1, PHASE2 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated May 17, 2026 03:11 UTC
-
New drug for skin conditions tested in small study
Symptom relief TerminatedThis study tested a new drug called XmAb27564 in 23 people with plaque psoriasis or atopic dermatitis (eczema). The main goal was to see if the drug is safe and tolerable when given as multiple injections. The trial was stopped early, and results are not yet available.
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Symptom relief
Last updated May 17, 2026 03:10 UTC